首页|期刊导航|药物分析学报(英文)|Push forward LC-MS-based therapeutic drug monitoring and pharmacometabolomics for anti-tuberculosis precision dosing and comprehensive clinical management
Push forward LC-MS-based therapeutic drug monitoring and pharmacometabolomics for anti-tuberculosis precision dosing and comprehensive clinical management
Nguyen Quang Thu Nguyen Tran Nam Tien Nguyen Thi Hai Yen Thuc-Huy Duong Nguyen Phuoc Long Huy Truong Nguyen
药物分析学报(英文)2024,Vol.14Issue(1):16-38,23.
药物分析学报(英文)2024,Vol.14Issue(1):16-38,23.DOI:10.1016/i.ipha.2023.09.009
Push forward LC-MS-based therapeutic drug monitoring and pharmacometabolomics for anti-tuberculosis precision dosing and comprehensive clinical management
Push forward LC-MS-based therapeutic drug monitoring and pharmacometabolomics for anti-tuberculosis precision dosing and comprehensive clinical management
摘要
关键词
Tuberculosis/Therapeutic drug monitoring/LC-MS/MIPD/Pharmacometabolomics/Precision medicineKey words
Tuberculosis/Therapeutic drug monitoring/LC-MS/MIPD/Pharmacometabolomics/Precision medicine引用本文复制引用
Nguyen Quang Thu,Nguyen Tran Nam Tien,Nguyen Thi Hai Yen,Thuc-Huy Duong,Nguyen Phuoc Long,Huy Truong Nguyen..Push forward LC-MS-based therapeutic drug monitoring and pharmacometabolomics for anti-tuberculosis precision dosing and comprehensive clinical management[J].药物分析学报(英文),2024,14(1):16-38,23.基金项目
This study was sponsored by the National Research Foundation of Korea(NRF)Grant funded by the Korean government(MSIT)(Grant No.:2018R1A5A2021242). (NRF)